Search Results - "Rustin GJS"

Pazopanib and Fosbretabulin in recurrent ovarian cancer (PAZOFOS): A multi-centre, phase 1b and open-label, randomised phase 2 trial.

Authors: Morgan RD Banerjee S Hall M et al.

Source: Gynecologic oncology [Gynecol Oncol] 2020 Mar; Vol. 156 (3), pp. 545-551. Date of Electronic Publication: 2020 Jan 10.

Publication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE